We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Through this mini-series of articles, we want to present you our whole team and skills of each.

  • Hello Audrey, could you please introduce yourself?

My name is Audrey Thiebaut and I hold a doctorate in the fields of molecular and cellular biology since December 2019. I carried out my thesis, in Caen, in PhIND laboratory directed by Pr. Denis Vivien. My thesis work focused on the role of tissue plasminogen activator (tPA) in autophagy during cerebral ischemia. Then, I did a post-doctorate at Sorbonne University during which I worked on DNA breaks and repairs in Huntington’s disease. I joined Op2lysis in March 2022 as R&D Project Manager. The main objective of my function is to participate, on the one hand, in the development of products portfolio on the basis of the NANOp2LysisTM technological platform and to participate, on the other hand, in the scientific valuation of Op2lysis.

  • Why did you choose to join the Op2Lysis team?

At first, it was the project that made me want to join Op2lysis. Hemorrhagic stroke is a socio-economic burden with no currently approved treatment. I have worked on stroke for more than 4 years, so it is a subject that matters a lot for me and I know how important and necessary it is to find an effective treatment. The idea of taking an active part in the design of a drug grew during my university experience, which was also very rewarding. Op2Lysis offered me this opportunity within a dynamic team. I now have the opportunity to use my knowledge in the development of an innovative project.

  • What is the strength of Op2Lysis?

In my opinion, the strength of Op2lysis is its multidisciplinary and complementary team. The team has been built to ensure that it has the necessary skills as the technology grows up. The preclinical, manufacturing, toxicological and entrepreneurial skills enable rapid progress towards the clinic. I am very happy to be able to contribute with the scientific and project management skills that I have developed during my training and academic experience..

  • What is your personal contribution to Op2lysis?

My career has allowed me to acquire an important knowledge in neuroscience and more particularly in stroke. I worked for more than 4 years on tissue plasminogen activator, and I was able to efficiently take over and complete a project on genetic, molecular and cellular alterations in Hungtinton disease. I am therefore immediately operational to manage the scientific projects of the company. I want to use my scientific knowledge to participate in the development of a portfolio of products based on the NANOp2lysisTM technological platform.lls that I have developed for such growth.